PHARMACOKINETIC [resa]
Evaluation [ftcn]
Triiodothyronine [aapp, horm, phsu]
Supplementation [topp]
Children [aggp]
Modified [ftcn]
Fontan Procedure [topp]
Triiodothyronine [aapp, horm, phsu]
T-3 [aapp, horm, phsu]
Supplementation [topp]
Management [ocac]
Patients [podg]
Cardiopulmonary Bypass [topp]
Limited [ftcn]
Available [ftcn]
Pharmacokinetics [phsf]
T-3 [aapp, horm, phsu]
Children [aggp]
Present [qnco]
Study [mnob]
Performed [ftcn]
Evaluate [ftcn]
T-3 [aapp, horm, phsu]
Pharmacokinetics [phsf]
Children [aggp]
Modified [ftcn]
Fontan Procedure [topp]
Methods [inpr]
Patients [podg]
randomized [resa]
Study, Prospective [resa]
Patients [podg]
divided [ftcn]
4 groups [inpr]
Group [idcn]
Received [qlco]
placebo [topp]
3 groups [inpr]
Received [qlco]
Intravenous [spco]
Dosages [qnco]
mU/kg [qnco]
Patients [podg]
SURVIVE [phsu]
operative procedures [ftcn]
Patients [podg]
Low Cardiac Output [fndg]
Patients [podg]
Pleural effusions [dsyn]
Length [qnco]
Hospital Stay [tmco]
7 days [tmco]
free [ftcn]
pg/dL [qnco]
Then [tmco]
Administration [ocac]
placebo [topp]
Patients [podg]
Received [qlco]
T-3 [aapp, horm, phsu]
Peak level [qnco]
free [ftcn]
pg/dL [qnco]
Dosages [qnco]
mU/kg [qnco]
Calculated [ftcn]
Half-Life [tmco]
T-3 [aapp, horm, phsu]
7 Hours [tmco]
Conclusions [idcn]
Half-Life [tmco]
Intravenous [spco]
Children [aggp]
Approximately [qlco]
Reported [inpr]
Adults [aggp]
Study [mnob]
Efficacy [qlco]
T-3 [aapp, horm, phsu]
Supplementation [topp]
Children [aggp]
Open heart surgery [topp]
